Mateos, M., Magen, H., Gatt, M., Sebag, M., Kim, K., Min, C., Ocio, E., Yoon, S., Chu, M., Rodriguez-Otero, P., Avivi, I., Carde, N. Q., Krevvata, M., Henninger, T., Thakkar, P., Festa, M., Huang, L., Zhou, J., Takamoto, M., Pei, L., Lu, J., Maffucci, C., Scott, E., Oriol, A., Morillo, D., Cohen, Y. (2025). Safety and efficacy of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma from Phase 1b of redirectt-1: Results with an extended median follow-up of 3 years. Blood. https://doi.org/10.1182/blood-2025-701